BioMarin Pharmaceutical Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BMRN for the last quarter is 648.33 M USD, and it's 0.38% higher compared to the previous quarter. The net income of Q1 24 is 88.66 M USD.